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Catheter ablation is now recognized as one of the potent options to reduce the number of implantable
cardioverter deﬁbrillator (ICD) shock therapies by modifying arrhythmic substrate in patients affected by
ventricular tachycardia (VT). However, operators often face some difﬁculties during mapping and
ablation procedure of VT; unstable VT makes it difﬁcult to create activation map, the thick ventricular
myocardium yields complex tachycardia circuit, and endocardial radiofrequency (RF) energy application
hardly creates transmural lesion. Thus some novel approaches are required to improve outcome of VT
ablation. Substrate mapping aiming low voltage or abnormal fragmented potential could identify the
critical slow conduction area during sinus rhythm and deﬁne the target of RF delivery. CT and MRI image
integrated to electroanatomical mapping (EAM) system also could help to ﬁnd diseased myocardium.
In this article focused on VT mapping procedure, conventional and novel mapping technique as well
as some technical tips should be reviewed comprehensively.
& 2014 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
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1. Introduction
Implantable cardioverter deﬁbrillator (ICD) therapy has
improved the prognosis of patients with lethal ventricular arrhyth-
mias [1–3]. The ICD terminates episodes of ventricular tachycardia
(VT) and saves patients from sudden cardiac death; however, it
does not change the arrhythmogenic substrate. Previous studies
have shown that patients who receive shock therapy have a poorer
prognosis [4], which suggests the necessity of supplemental
preventive therapy to reduce the ICD shock frequency. The
indication for antiarrhythmic drugs is strictly limited because of
their negative inotropy, proarrhythmic effect, and poor compliance
[5]. Catheter ablation is now recognized as the most potent non-
pharmacological option to modify the reentrant arrhythmogenic
circuit and in some clinical studies has actually been proved to
reduce the number of ICD shocks [6,7]. However, poor inducibility
of the index VT, concomitant non-clinical VT, and hemodynamic
and electrical instability often make it difﬁcult to perform activa-
tion mapping during VT. Moreover, radiofrequency energy applied
endocardially is sometimes insufﬁcient to create transmural
lesions across thick ventricular myocardium. Thus, to achieve
success in VT ablation, some novel approaches are required in
addition to conventional mapping and ablation techniques. When
activation mapping is not available, identiﬁcation of the substrate
that forms the critical part of the reentrant circuit during sinus
rhythm enables mapping in a hemodynamically stable condition,
and permits a strategy for ablation even in non-inducible patients.
The bipolar/unipolar scar identiﬁed by the electroanatomical
mapping (EAM) system, late enhancement detected by CT/MRI,
and late or fractionated local activity could be potential targets for
ablation. In a number of cases, the VT circuit could be located in
the epicardium or even in an intramural layer. Thus, it is important
to identify the substrate optimally at the beginning of the
procedure and to prepare an appropriate approach (transaortic,
transseptal, or epicardial). With better technology, such as contact
force monitoring, high-deﬁnition mapping catheters, and new
signal processing algorithms, our understanding of VT substrate
mapping will improve in the near future. In this article, the
present strategy of procedures for the mapping and ablation of
VT is reviewed.
2. Preparation of the procedure
2.1. 12-Lead ECG
It is highly advisable to obtain a 12-lead recording of sponta-
neous or “clinical” VT before the procedure, not only because it can
be used as a reference for induced VT or pace mapping during the
procedure, but also because it provides rough information about
the origin of the tachycardia. Generally, a right bundle-branch
block pattern in lead V1 suggests that the tachycardia originates
from the left ventricle, while tachycardia from the right ventricle
or intraventricular septum presents as a left bundle-branch block
pattern. The electrical axis of the QRS complex reﬂects the
direction of the activation wavefront in the frontal plane; i.e.,
positive QRS in inferior leads (II/III/aVF) indicates that the VT
comes from the antero-superior part, whereas a negative QRS
complex represents an inferoposterior origin. On the other hand,
positive concordance in the precordial leads means that the VT
origin is located in the basal area, while negative concordance
suggests the VT origin is located apically [8,9]. The transitional
zone and the change of polarity (positive to negative or negative
to positive) provide information about propagation in the
horizontal plane.
Epicardial VT usually reveals a wide QRS duration with a slow
upstroke from onset to peak [10,11], because it takes a relatively
long time before the activation wavefront captures the His–
Purkinje system with rapid conduction located in the endocar-
dium. A careful estimation of the VT morphology should be taken
into account when judging the necessity for an epicardial
approach in the actual procedure.
Regardless of whether they are ischemic or non-ischemic, a
considerable number of patients have multiple VT. Detailed
analysis of each VT morphology gives an outline of the VT circuit
(i.e., whether each VT circuit shares a common isthmus or is totally
independent) and thus provides important information for plot-
ting treatment strategy.
2.2. Anatomy acquisition and scar identiﬁcation by MRI or CT
In the absence of any contraindication, such as renal dysfunc-
tion or electrical devices, it is highly recommended to obtain
enhanced MRI or CT images as far as possible before the mapping
procedure. The CT or MRI image can be merged with the electro-
anatomical mapping system and improves the accuracy of the
map. Anatomical information, such as the size of the ventricle, the
location of coronary arteries, and the distribution of epicardial fat,
provides important information for an adequate mapping strategy
or identiﬁes potential risks [12,13]. Moreover, the abnormal
damaged myocardium, which can play a critical role in the VT,
can be detected by late enhancement [14–16].
2.3. General preparation
Generally, patients who have VT associated with structural
heart disease have impaired cardiac function and poor tolerability
for the treatment procedure. For successful VT ablation, it is
essential to design a procedural strategy that is based on the
patient's background, the characteristics of the tachycardia, possi-
ble procedural risks, and any other conditions. As even tolerable
VT sometimes loses its hemodynamic stability easily under trig-
gers such as drug administration and radiofrequency energy
delivery, it is mandatory to make a standby mechanical support
system (PCPS, ECMO, or IABP) available in any VT case [17–19], as
well as estimating the cardiac capacity thoroughly using echocar-
diography, coronary angiography, and other possible modalities
before the procedure.
For an epicardial approach or hemodynamically unstable VT,
intensive care—including general anesthesia and mechanical sup-
port in collaboration with an anesthetist or cardiac surgeon—is
often required [20]. On the other hand, the inducibility and
sustainability of VT are decreased under general anesthesia, which
makes the mapping procedure during VT difﬁcult; thus, substrate
mapping might be a major tool for identifying the target of
ablation.
2.4. Access and catheter settings
To avoid a risk of excess bleeding followed by possible iatro-
genic trauma, all access should be performed before the adminis-
tration of heparin. Left ventricular endocardium can be accessed
by two approaches: retrograde transaortic and antegrade trans-
septal. Which approach is more preferable depends on the loca-
tion of the target site in the ventricle.
Technically, we usually use the 8.5 Fr armored long sheath
(Super Arrow-Flex, Arrow International Inc., Reading, PA, USA) for
the retrograde transaortic approach, which can straighten the
femoral artery and provide easier delivery of the catheter to the
descending aorta. For the transseptal approach, an SL0 sheath is
used for the initial puncture, and is then replaced by a manually
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controlled steerable sheath (Agilis, St. Jude Medical, Minneapolis,
MI, USA). The tip of the sheath should be placed at the level of the
mitral annulus with the mapping catheter tip protruding at least
3 cm from the sheath.
The subxiphoidal pericardial puncture is currently performed
using the technique originally proposed by Sosa et al. [21,22].
For an inferior epicardial approach, starting from the border of
the subxiphoid, a Tuohy needle is advanced toward the middle
inferior wall of the right ventricle, generally at 451 to the skin's
surface and at the same angle to the middle line of the sternum. In
some cases, a selective approach to the anterior wall of the right
ventricle may be useful, in which case the angle between the needle
and skin surface should be smaller than the conventional 451.
Catheters positioned in the right ventricle apex and coronary sinus
will be good landmarks. Continuous ﬂuoroscopic monitoring in
right and left anterior oblique views is recommended during the
advancement of the needle tip toward the cardiac silhouette.
A small amount of contrast medium will make it easier to see
tenting of the pericardium. Monitoring the pressure of the tip of
the needle is also a useful technique: once the needle goes into
the pericardial space, the pressure usually drops steeply and the
oscillating pressure curve clearly indicates penetration of the needle
tip into the ventricle. With the conventional Seldinger technique, a
9-F sheath introducer is positioned in the pericardial space so that
the mapping catheter may be inserted, while also allowing ﬂuid to
be drained through the side port. To avoid the risk of losing access,
we prefer to use a long sheath (23 cm) instead of the conventional
11 cm sheath. Another recommendation is to verify the position of
the sheath by injecting a small amount of contrast media into the
pericardial space before removing the wire.
3. Initial induction of ventricular tachycardia
Commonly, VT induction by programmed ventricular stimula-
tion (PVS) is attempted at the beginning of the procedure, except
in some cases, such as when clinical VT has already been
documented with reproducibility, the patient exhibits incessant
or spontaneous VT, and the ablation target is clearly identiﬁed.
Although the relationship between the inducibility of VT and
clinical VT has not been fully elucidated, induced VT provides
some useful information [23]. The presence or absence of VT
inducibility, the hemodynamic stability or sustainability of the
induced VT, and the VT morphologies help to determine the
procedure strategy, required support (including extracorporeal
circulation or surgical approach), and endpoint.
It is advisable to perform initial VT induction with the patient
in a waking state, as general anesthesia markedly modiﬁes the
inducibility of VT by PVS. If VT is not induced easily, repeated PVS
(with maximum 4 extrastimuli or burst pacing) is delivered at a
different basic cycle length or different site (right ventricular apex,
right ventricular outﬂow tract, or left ventricle). If necessary,
isoproterenol may be administered.
4. Conventional mapping and ablation of ventricular
tachycardia
4.1. Possible target of VT ablation
For the initiation and maintenance of VT, triggers are usually
required in addition to an anatomic substrate. The electrophysio-
logical condition of triggering is not always consistent and may
be affected by the status of the patient, such as heart failure,
myocardial ischemia, abnormal blood levels of electrolytes, or
autonomic imbalance.
In coronary artery disease, most VTs arise from a reentrant
circuit containing a typical slow-conduction zone, usually pro-
tected and located within the infarct scar or between the scar and
an anatomical obstacle such as the mitral annulus.
On the other hand, VTs in patients with non-ischemic cardio-
myopathy (NICM) are more heterogenous [24–26]. The abnormal
conduction properties of NICM are caused by deletion of myocytes,
replacement by interstitial ﬁbrosis, and myocardial disarray rather
than necrosis. Ischemic scar is located predominantly in endocar-
dial myocardium, whereas the VT substrate of NICM is detected in
endocardial, epicardial, or even in intramural myocardium [27].
The substrate in NICM VT is often more diffuse, more atypical,
with a wider spectrum than ischemic VT, and occasionally may
even be difﬁcult to identify. Moreover, the potential mechanism of
NICM VT is triggered activity in addition to reentry [28,29]. For
these reasons, VTs in NICM patients are less monomorphic and are
infrequently induced during EP studies.
It is often difﬁcult to determine the reentrant circuit in patients
with polymorphic VT. In some cases, polymorphic VTs may be
initiated by a speciﬁc ectopic beat with unique morphology, which
can be also a target of ablation.
4.2. Activation mapping during VT
When spontaneous or induced VT is hemodynamically and
electrophysiologically stable, the exit from the slow-conduction
area can be identiﬁed by the earliest activation site of the
activation map obtained during VT, using an electroanatomical
mapping system such as CARTO3 (Biosense Webster, CA) or EnSite
(St. Jude Medical, MN). The onset or peak of the QRS complex on
the surface ECG, or local potentials of the electrode catheter
positioned at the RV apex can be used as reference.
A presystolic potential is often observed near the exit site of the
slow-conduction area during VT, and is especially common among
patients who have ischemic VT with scar. Typically, as the tip of
the recording catheter moves proximally, this potential precedes
gradually, being seen during the mid-diastolic phase in the
isthmus and just after the QRS on entry to the slow-conduction
zone [30]. It is sometimes difﬁcult to detect these speciﬁc
potentials, especially when only a little viable myocardium
remains. On the other hand, they are recorded even in innocent
bystander sites in the slow-conduction area. Overdrive pacing
from the site with diastolic or presystolic potentials during VT is
useful in order to characterize the position of the catheter in the
slow-conduction area; if the catheter tip is located in the critical
isthmus, the stimulus-QRS interval is identical to the interval
between the local potential and the QRS (EGM-QRS). If the
catheter is positioned in a bystander site, the stimulus-QRS
interval should be longer than the local EGM-QRS.
4.3. Entrainment mapping during VT
Overdrive pacing intervention during VT from a different site is
often utilized to investigate the mechanism of the tachycardia and
to determine the position and distance between the pacing site
and the tachycardia circuit [31,32].
Pacing during VT at a slightly higher rate produces a fused QRS
morphology composed of the orthodromic wavefront from the VT
itself and the antidromic wavefront due to pacing. When VT is
induced by increased automaticity, pacing does not affect the
tachycardia rate; thus, the degree of fusion differs beat by beat.
Meanwhile, when the VT is reentrant, a paced impulse that enters
and passes through the reentrant circuit breaks out from the exit to
form an orthodromic wavefront and then collides against an
antidromic wavefront formed by the next pacing impulse. As the
paced impulse constantly resets the tachycardia, the degree of
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fusion is ﬁxed and reveals consistent QRS morphology (constant
fusion). At the end of pacing, the last paced impulse enters/emerges
from the circuit and activates the whole ventricle without collision
against the next impulse. Thus, the last pacing beat produces only
the orthodromic wavefront, resulting in the same QRS morphology
as clinical VT. A higher pacing rate makes the fusion occur more
proximally to the circuit, i.e., it yields a greater area captured by
pacing in an antidromic manner. As a result, with an increasing
pacing rate, the morphology of the fused QRS remains constant, and
gradually becomes dominated by a paced QRS morphology rather
than the clinical VT (progressive fusion). The same phenomenon is
observed in the intracardiac electrogram. The change in activation
timing, polarity, and morphology of a speciﬁc local potential caused
by a change in the pacing rate means that the manner of capture of
the local corresponding myocardium has shifted from orthodromic
to antidromic. Termination of the VT presents a different activation
pattern, since the next pacing impulse can no longer fuse with the
orthodromic wavefront.
The interval between the ﬁnal pacing spike and next local
activation (PPI: post pacing interval) presents as: PPI¼conduction
time from pacing site to reentrant circuitþcycle length of
VTþconduction time from reentrant circuit to pacing site.
If the myocardium is paced within the reentrant VT circuit, the
conduction time between the pacing site and the circuit should
be zero; thus, PPI is equal to cycle length. Furthermore, when
myocardium in the slow-conduction zone is paced, the antidromically
captured area is limited to within slow-conduction area, without any
contribution to form the surface QRS; thus, the surface QRS morphol-
ogy remains identical to that of the clinical VT.
4.4. Pace mapping
In case previously documented clinical VT is not induced or
unstable, pace mapping can be used. The origin of VT is investigated
by comparing the paced QRS conﬁguration obtained from different
parts of the ventricle with that of the clinical VT. When the paced
QRS morphology is completely matched (12/12 leads) to the clinical
VT, it is considered “ideal.” When 10–11/12 leads match, the paced
QRS is regarded as “good.” The stimulus-QRS interval also provides
useful information; a site with stimulus-QRS latency more than
80 ms is more likely to be an ablation target [33].
It is recommended to pace using the same cycle length as that
of the clinical VT. Broad capture by high-output pacing or bipolar
pacing can alter the QRS morphology. Even within the true critical
VT isthmus area, pacing from the site near the entrance of the
isthmus with a long stimulus-QRS interval can also yield a
different QRS morphology, because an antidromic wavefront can
propagate through normal myocardium, while the wavefront
spreads in one direction from the site of origin to the remainder
V3
mapping distal
mapping proximal
Fig. 1. (A) Bipolar voltage map of the left endocardium (left panel) and epicardium (right panel) of a 66-year-old male with an inferior myocardial infarction. Transmural
infarct scar is observed in the basal inferolateral and mid-inferior wall. (B) Local electrograms in the infarct scar (indicated as yellow points). The latency of late activity is
greater in epicardium compared to endocardium. In fact, it required epicardial radiofrequency delivery in addition to endocardial ablation in order to obtain non-inducibility
of ventricular tachycardia.
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of the heart during clinical VT. The absence of functional block
during pace mapping under sinus rhythm, which is commonly
observed during clinical VT, can also produce a different QRS
conﬁguration.
In contrast, pacing from a non-critical bystander site in a slow-
conduction area can occasionally produce a QRS morphology
identical to that of the clinical VT, as the surface QRS starts when
the local activation exits the area and propagates into normal
myocardium.
Therefore, the spatial resolution of pace mapping is not as high
as that of activation mapping during VT. Although pace mapping is
a useful method for the localization of a small VT focus in a
structurally normal heart, such as outﬂow VT, its advantage might
be smaller in VT patients with structural heart disease. Especially
when the VT originates from intramural myocardium or epicar-
dium, far from the endocardium, the reliability of pace mapping is
relatively poor.
5. Substrate mapping during sinus rhythm
As mentioned above, conventional mapping, including identiﬁca-
tion of the earliest activation site and critical slow-conduction isthmus
by activation mapping or entrainment during spontaneous/induced
VT, has been widely utilized in the mapping of supraventricular
tachycardias. Essentially, these mappings are performed during VT
and are not available in a patient with collapsing VT. Moreover, the
inducibility of VT is not high and, even in a patient who has had
recurrent episodes, clinical VT cannot always be induced. These
technical issues of conventional mapping have been associated with
the low success rate of mapping/ablation procedures for VT. Recently
developed electroanatomical mapping systems have introduced the
new concept of substrate mapping, which provides information about
abnormal myocardium andmakes it possible to deliver radiofrequency
(RF) energy to the target substrate of the VT circuit during sinus
rhythm.
5.1. Voltage mapping
Voltage mapping is based on the concept that abnormal
myocardium delivers a low voltage and can form a critical slow-
conduction area that can be detected using reconstructed data of
the voltage amplitude for each point in the ventricle, obtained
using an EAM system (Fig. 1). Pathologically, slow conduction is
caused by anisotropy due to missing or ﬁbrous myocardium. In
such areas, which lack a sufﬁcient volume of intact myocardium,
the total voltage should be decreased. Commonly, the area con-
structed by points with a bipolar voltage amplitude o0.5 mV is
deﬁned as dense scar, while the area between 0.5 and 1.5 mV is
designated as a low-voltage area. Based on the voltage map,
Fig. 2. (A) Bipolar voltage map of the epicardium (left panel) and left ventricular endocardium (right panel) of a 61-year-old male patient with non-ischemic
cardiomyopathy. In the epicardial map, dense scar with signal voltage less than 0.5 mV appears as a red area and the low voltage (signal voltage between 0.5 and
1.5 mV) areas in yellow and green are located in the basal inferior and mid-inferior wall, whereas the endocardial voltage map is normal. Small red dots indicate ablation
points. (B) Local activation time map during sinus rhythm. The late potential area is located between two inferior scars. (C) Local electrogram taken at the yellow point in the
late potential area. A discrete isolated potential is observed. Total abolition of these potentials resulted in non-inducibility of ventricular tachycardia.
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conduction channels are often identiﬁed as regions located within
dense scar or between the scar and an anatomical obstacle (Fig. 2)
[34,35].
In typical myocardial infarction-related VT, the exit is usually
located in the scar border zone. Thus, it is important to take as
many points as possible along the scar to create a precise map
with maximum resolution. A pacing maneuver is helpful to
identify and characterize the conduction properties within the
scar or border zone; the failure to capture a paced impulse
provides information about ﬁxed conduction block. The paced
QRS morphology and stimulus-QRS interval also help to identify
the conducting channel.
5.2. Abnormal potential mapping: late potentials and local abnormal
ventricular activity
Within a diseased area, the local electrogram is generally
characterized by low voltage, high frequency, and a long-lasting
“fragmented” potential [36] caused by local conduction block or
anisotropies among the myocardial bundle. Sometimes, an isolated
discrete delayed potential is also observed. Typically, along the
border of a myocardial infarct scar, a large and dull signal
representing far-ﬁeld signals of normal myocardium is followed
by small, continuous, or isolated high-frequency signals. This
small, fragmented potential is deﬁned as the late potential if it is
recorded after the end of the surface QRS. It can be a useful item
for identifying conduction delay as a target of RF ablation. The
latency or duration is likely to be associated with a slow-
conduction isthmus, and in this context [24,37], total abolition of
late potentials might be an endpoint of catheter ablation (Fig. 3).
Previous studies have shown that this ablation strategy provides a
favorable success rate [38].
Although late potentials are one established target for ablation,
there remains an issue. The detection of late potentials is affected
by such factors as the morphology of the QRS complex, the
location of the slow-conduction area, and the direction of the
activation wavefront. For example, when the slow-conduction area
is located in the septal wall, the abnormal fragmented potential is
buried within the QRS. The presence of right bundle-branch block
also can mimic negative late potentials in the left ventricle. In such
cases, the abnormal fragmented potential is often recorded within
the QRS or normal far-ﬁeld activity and is never detected as a
“late” potential. The potential of the conduction system sometimes
Fig. 3. (A) Local activation time (LAT) map (upper panel) obtained from a 34-year-old male post-myocarditis. Local late activity (lower panel) is located in the epicardial
apical-anterior area (indicated as purple). (B) Mid-diastolic potential seen in the same area during clinical ventricular tachycardia. (C) Relatively good correspondence of QRS
morphology obtained by pacing from the same point. (D) LAT remap after epicardial ablation. Total abolition of the late potential resulted in non-inducibility of clinical
ventricular tachycardia.
H. Mizuno / Journal of Arrhythmia 30 (2014) 283–291288
forms multiple components and can be another factor that makes
it difﬁcult to distinguish the pathological fragmentation from the
normal electrogram in the septal wall. Jaïs et al. reported the
utility of pacing when such an abnormal high-frequency potential
is observed within the QRS complex [39]. If the abnormal
component can be separated by pacing from different sites, it
suggests the presence of multiple conduction properties, possibly
including critical slow conduction. Although the detection and
conﬁrmation of such fragmented activity by pacing is time-con-
suming, it can be useful to avoid overlooking it. Investigation is
continuing into methods of separating these potentials from
normal far ﬁeld potentials directly, using signal processing tech-
niques such as frequency analysis.
How speciﬁc these abnormal potentials are for a critical
isthmus is an important question that remains to be solved. Total
abolition of these potentials can eliminate all possible VTs, which
can be critical in the future; however, it might involve a great area
that includes innocent bystander sites. To improve the diagnostic
accuracy or to clarify the pathological meaning of the potentials,
additional features of the local electrogram, including the response
to pacing, are recommended.
6. Technical issues
6.1. Importance of contact force monitoring during substrate
mapping
The importance for accurate mapping of appropriate contact
between the myocardial tissue and the catheter tip is widely
recognized [40]. In ablation procedures, since the tip temperature
feedback is practically meaningless for controlling lesion forma-
tion using irrigated catheters, the importance of contact force (CF)
monitoring should be also emphasized.
As previous studies using non-irrigated ablation catheters have
shown that CF is a predictor of successful lesion creation and
complications during RF application, the importance of appropriate
CF has been widely recognized since the early days of catheter
mapping and ablation procedures. In the absence of a direct quanti-
tative indicator of CF, many attempts to identify surrogate parameters
of “good contact” have been made in the past, including direct
visualization of the tip of the catheter with ﬂuoroscopy or echocardio-
graphy, or indirect quantitative parameters, such as ST-segment
elevation on the unipolar electrogram and changes in temperature
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Fig. 4. (A) Unipolar voltage map of points taken with insufﬁcient (upper panel) and sufﬁcient (lower) contact force. The unipolar scar seems to be bigger with insufﬁcient
contact force. (B) Frequency of late potentials in normal tissue, low voltage area, and dense scar. Late potentials were detected more frequently with good contact,
independently of myocardial tissue characteristics. (C) A case in which increased contact force was associated with effective ablation. During the initial 30 s, radiofrequency
energy was delivered with a mean contact force (white line in lower panel) of 15 g to the endocardial basal anterolateral wall without any effect. Four seconds after the
contact force increased to 40 g, the ventricular tachycardia terminated.
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or impedance during ablation. However, since the relationship
between these surrogate indicators and actual CF has not been fully
elucidated, no data on the adequate CF to be used in clinical settings
will be available until we see improvements in real-time force sensing
technology.
To evaluate the importance of CF monitoring during a VT
mapping procedure, we measured CF using SmartTouch in 27
chambers (6 endocardial maps of the right ventricle, 13 endocar-
dial maps of the left ventricle and 8 epicardial maps) of 17 patients
[41]. Of all 8892 points reviewed, 5926 that had stable recordings
across at least 2 s were subjected to further analysis. The fre-
quency of points taken with poor contact (without positive force
during diastole) reached 26%, despite all the operators’ efforts to
obtain constant contact based on classical surrogate indicators.
There was a categorical change in electrophysiological parameters
such as bipolar and unipolar signal amplitude or local impedance
with relatively low CF. Furthermore, points with late potentials
were more frequent in the good contact group, which was
consistent across the characteristics of the myocardial tissue
(normal, low voltage area, and scar). Our data suggest that
sufﬁcient CF is needed to create a precise substrate map, especially
for the recognition of abnormal late activity, as well as to deliver
sufﬁcient RF energy (Fig. 4).
6.2. Usefulness of steerable sheath in endocardial and epicardial
mapping
Generally, perspective and precise maps, as well as stable
contact between the ablation catheter and myocardial tissue, are
indispensable for all successful procedures. This is especially true
in substrate mapping and VT ablation procedures, which require
high resolution to identify an abnormal substrate and intense RF
energy to create a transmural lesion. However, the possibility of
reaching the whole myocardial surface and gaining a ﬁne contact
with the desired location is often hampered by insufﬁcient back-
up force via a standard sheath. A manually controlled steerable
sheath provides a greater range of orientation and stable contact
[42]. Previous observational and randomized prospective studies
have already clariﬁed the utility of this steerable sheath in
procedures for cavotricuspid isthmus ablation and pulmonary vein
isolation in patients with atrial ﬂutter and ﬁbrillation. This
advantage of the steerable sheath should be maximized to
improve the efﬁcacy of VT procedures.
7. Conclusion
Three-dimensional electroanatomical mapping systems have
provided a great deal of fundamental information about the VT
substrate, which has extended the indications for VT ablation to
unstable VT, which had been unmappable with conventional
techniques. An electrophysiologically abnormal area with low
voltage or fragmented potentials is now established as a potential
target for ablation. However, its sensitivity and speciﬁcity in
identifying a true critical isthmus need to be improved. Whether
to ablate all abnormal substrates that can produce non-clinical VT
is another remaining question. In the future, not only anatomical
but also functional information, such as quantiﬁed wall motion or
metabolism, may be integrated into EAM systems to provide a
precise appreciation of the VT substrate.
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